Mark Brosius, an executive vice president and Chief Manufacturing and Supply Chain Officer at Intuitive Surgical Inc., has reported the sale of 183 shares of the company's common stock over a span of three days. These transactions, which occurred on October 26, 27, and 28, 2026, are part of a structured trading plan that complies with SEC Rule 10b5-1.

The sales were executed at prices ranging from $441.60 to $451.75 per share, reflecting a strategic adjustment in the executive's stock holdings. Following these transactions, Brosius retains ownership of 581 shares. The structured nature of these sales suggests a planned approach to managing stock holdings, a common practice among corporate executives.

Background

Intuitive Surgical Inc. is a leading company in the medical device industry, known for its innovative robotic surgical systems. The company is incorporated in Delaware and operates under the Central Index Key (CIK) 0001035267. It specializes in orthopedic, prosthetic, and surgical appliances and supplies. The company's fiscal year ends on December 31.

What the Filing Says

According to the recent SEC filing (accession number 0002010300-26-000035), Brosius executed three transactions to sell shares. The filing states, "The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027." This indicates that the sales were pre-planned and executed within the framework of SEC regulations.

Impact

These transactions may impact the perception of executive confidence in the company's stock among investors and analysts. As part of the executive team, Brosius's actions could influence market sentiment regarding Intuitive Surgical's future performance. The medical device industry remains competitive, and such transactions can reflect broader trends in executive stock management.

What's Next

The filing does not say what happens next.